Yale University Epidemiologist Publishes Paper on Major Benefits of Hydroxchloroquine for High-risk Outpatients. Quacksalvers like Fauci should put lives ahead of Politics
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
Dr. Harvey A. Risch
Published May 27, 2020
DEPARTMENT OF CHRONIC DISEASE EPIDEMIOLOGY , YALE SCHOOL OF PUBLIC HEALTH.
https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586
"Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
Dr. Harvey A. Risch
Published May 27, 2020
DEPARTMENT OF CHRONIC DISEASE EPIDEMIOLOGY , YALE SCHOOL OF PUBLIC HEALTH.
https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586
"Evidence about use of hydroxychloroquinealone, or of hydroxychl
